500% profit margins on drugs: Study

New Delhi A suo motu study on drug pricing by the Ministry of Corporate Affairs has revealed exorbitant profit margins on 21 common drugs manufactured by Indian companies.

Read More
Publication Date: 
23/07/2012
Abantika Ghosh
Financial Express (New Delhi)
Tags:
India, Drugs, Ministry of Chemicals and Fertilizers, Ministry Of Health And Family Welfare, Ranbaxy Pharmaceuticals, Health Care, Planning Commission, Drug Industry, Industry